Press Releases
Global brain and vision research nonprofit BrightFocus Foundation has appointed three industry leaders to its board of directors.
Global nonprofit BrightFocus Foundation is pleased to announce that it has received a $50,000 donation from Alzheimer’s Los Angeles (Alzheimer’s LA) to support two innovative Alzheimer’s disease research scientists as part of the Foundation’s 2023 research portfolio.
BrightFocus Foundation hosted its 50th Anniversary Celebration and Awards on June 14 at the Smithsonian’s National Museum of the American Indian in Washington, D.C.
On Wednesday, June 14, BrightFocus hosted a bipartisan congressional briefing to highlight the importance of funding and diversity in research to improve health equity and cure brain and vision diseases.
In celebration of its 50th anniversary, BrightFocus Foundation announces the launch of a yearlong campaign and microsite celebrating the international nonprofit’s strides in the fight against Alzheimer’s disease, macular degeneration, and glaucoma and toward greater awareness of the importance of funding brain and vision research and education.
BrightFocus honors the life of Donald L. Price, MD.
The 2023 Helen Keller Laureates Gustavo D. Aguirre, VMD, PhD, Jean Bennett, MD, PhD, Samuel G. Jacobson, MD, PhD (posthumously), Albert M. Maguire, MD, and T. Michael Redmond, PhD, were awarded the 2023 Helen Keller Prize for Vision Research on April 25 by BrightFocus Foundation and the Helen Keller Foundation for Research and Education.
BrightFocus Foundation was honored on April 22 by the Association for Research in Vision and Ophthalmology (ARVO) in New Orleans.
BrightFocus Foundation, an international nonprofit funder of brain and vision research, recognized five leading vision scientists for their ideas to prevent, treat, and cure macular degeneration and glaucoma during the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO).
BrightFocus Foundation will support a new five-year research initiative in Canada that will study the aging brain and identify how to reduce the risks of dementia and other forms of cognitive impairment.
